Nina S. Kjellson
CIK: 0001381980
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (27 total)
- Jun 8, 2026ELOX
Eloxx Pharmaceuticals, Inc.
Award(A)DirectStock Option (Right to Buy)
13.6K shares- - Feb 5, 2025TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect3.5K shares at avg. $13.76$48K - Feb 5, 2025TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect1.9K shares at avg. $13.76$26K - Jan 23, 2025TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect4.8K shares at avg. $16.26$78K - Jan 21, 2025TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect4K shares at avg. $16.36$65K - Jan 17, 2025TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect12.8K shares at avg. $16.40$210K - Jan 17, 2025TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect461 shares at avg. $16.40$8K - Jan 16, 2025TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect835 shares at avg. $16.29$14K - Jan 16, 2025TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect6.9K shares at avg. $16.29$113K - Nov 25, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect4.7K shares at avg. $16.84$79K - Nov 25, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect566 shares at avg. $16.84$10K - Nov 7, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect2.4K shares at avg. $17.32$41K - Nov 7, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect19.7K shares at avg. $17.32$342K - Nov 6, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect46.9K shares at avg. $17.18$805K - Nov 6, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect5.6K shares at avg. $17.18$97K - Nov 5, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect1.1K shares at avg. $16.77$19K - Nov 5, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect9.4K shares at avg. $16.77$157K - Nov 4, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect116 shares at avg. $17.01$2K - Nov 4, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect960 shares at avg. $17.01$16K - Nov 1, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect2.9K shares at avg. $16.54$48K - Nov 1, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect604 shares at avg. $17.16$10K - Nov 1, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect23.9K shares at avg. $16.54$396K - Nov 1, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect73 shares at avg. $17.16$1K - Oct 31, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect10.8K shares at avg. $16.46$177K - Oct 31, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Indirect89.4K shares at avg. $16.46$1.5M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 8, 2026 |  ELOX Eloxx Pharmaceuticals, Inc. | Award(A) Stock Option (Right to Buy) | 13,587 | - | - | Direct |
| Feb 5, 2025 |  TYRA Tyra Biosciences, Inc. | Sale(S) | 3,511 | $13.76 | $48,315 | Indirect |
| Feb 5, 2025 | TYRA Tyra Biosciences, Inc. | Sale(S) | 1,890 | $13.76 | $26,008 | Indirect |
| Jan 23, 2025 | TYRA Tyra Biosciences, Inc. | Sale(S) | 4,825 | $16.26 | $78,466 | Indirect |
| Jan 21, 2025 | TYRA Tyra Biosciences, Inc. | Sale(S) | 3,993 | $16.36 | $65,336 | Indirect |
| Jan 17, 2025 | TYRA Tyra Biosciences, Inc. | Sale(S) | 12,808 | $16.40 | $210,052 | Indirect |
| Jan 17, 2025 | TYRA Tyra Biosciences, Inc. | Sale(S) | 461 | $16.40 | $7,560 | Indirect |
| Jan 16, 2025 | TYRA Tyra Biosciences, Inc. | Sale(S) | 835 | $16.29 | $13,600 | Indirect |
| Jan 16, 2025 | TYRA Tyra Biosciences, Inc. | Sale(S) | 6,944 | $16.29 | $113,097 | Indirect |
| Nov 25, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 4,706 | $16.84 | $79,242 | Indirect |
| Nov 25, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 566 | $16.84 | $9,531 | Indirect |
| Nov 7, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 2,371 | $17.32 | $41,061 | Indirect |
| Nov 7, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 19,720 | $17.32 | $341,513 | Indirect |
| Nov 6, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 46,856 | $17.18 | $804,775 | Indirect |
| Nov 6, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 5,635 | $17.18 | $96,784 | Indirect |
| Nov 5, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 1,126 | $16.77 | $18,881 | Indirect |
| Nov 5, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 9,367 | $16.77 | $157,069 | Indirect |
| Nov 4, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 116 | $17.01 | $1,973 | Indirect |
| Nov 4, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 960 | $17.01 | $16,326 | Indirect |
| Nov 1, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 2,878 | $16.54 | $47,615 | Indirect |
| Nov 1, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 604 | $17.16 | $10,364 | Indirect |
| Nov 1, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 23,938 | $16.54 | $396,040 | Indirect |
| Nov 1, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 73 | $17.16 | $1,253 | Indirect |
| Oct 31, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 10,750 | $16.46 | $176,941 | Indirect |
| Oct 31, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 89,390 | $16.46 | $1,471,324 | Indirect |
1-25 of 27 transactions
About Kjellson Nina S
Kjellson Nina S (SEC CIK 0001381980) files insider reports with the SEC as Director of Eloxx Pharmaceuticals, Inc. (ELOX) and Director of Tyra Biosciences, Inc. (TYRA).
Signal8 holds 9 ownership filings by Kjellson Nina S (1 Form 3, 8 Form 4), filed between Nov 1, 2024 and Jun 10, 2026. Those filings report 27 transactions, from Oct 30, 2024 to Jun 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kjellson Nina S's filings is in ARLINGTON, MA.
Recent filings by Kjellson Nina S
- Jun 8, 2026: Grant or award of ELOX derivative securities (Form 4, code A).
- Feb 5, 2025: Open-market sales of TYRA shares (2 lines, Form 4, code S).
- Jan 23, 2025: Open-market sale of TYRA shares (Form 4, code S).
- Jan 21, 2025: Open-market sale of TYRA shares (Form 4, code S).
- Jan 17, 2025: Open-market sales of TYRA shares (2 lines, Form 4, code S).
Other insiders filing for Eloxx Pharmaceuticals, Inc. (ELOX)
- Germano Geno J, Director
- Domicilium Real Estate Fund III LP, 10% Owner
- Webster Stephen W, Director
- Walts Alan Edmund, Director
- Aggarwal Sumit, President and CEO
- Rubin Steven D, Director